Osteogenesis Imperfecta Type III - 7 Studies Found
Completed |
: Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta :
|
Completed |
: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2009-09-21 : Drug: Zoledronic Acid Each patient is to receive an initial dose of zoledronic acid of 0.0125 mg per kg |
Recruiting |
: A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 :
|
Completed |
: Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2005-08-15 : Drug: Zoledronic Acid |
Completed |
: Growth Hormone Therapy in Osteogenesis Imperfecta : Osteogenesis Imperfecta : 1999-11-03 :
|
Completed |
: Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation : Osteogenesis Imperfecta : 2008-06-23 :
|
Not yet recruiting |
: Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta : Osteogenesis Imperfecta : 2016-10-13 : Drug: Fresolimumab The purpose of this study is to determine if fresolimumab is safe as a treatment for |